| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Can COVID-19 changes reduce stigma in African HIV clinics?
|
Lofgren, Sarah M
|
|
|
9 |
5 |
p. e304-e305
|
article
|
| 2 |
Cost-effectiveness of easy-access, risk-informed oral pre-exposure prophylaxis in HIV epidemics in sub-Saharan Africa: a modelling study
|
Phillips, Andrew N
|
|
|
9 |
5 |
p. e353-e362
|
article
|
| 3 |
Documenting the UK's 40-year battle with HIV/AIDS
|
Burki, Talha
|
|
|
9 |
5 |
p. e308
|
article
|
| 4 |
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
|
Waalewijn, Hylke
|
|
|
9 |
5 |
p. e341-e352
|
article
|
| 5 |
Empowering women: addressing HIV vertical transmission in the Philippines
|
Basilio, Patricia Anne S
|
|
|
9 |
5 |
p. e306
|
article
|
| 6 |
HIV and COVID-19: juxtaposition of two pandemics
|
Nkengasong, John
|
|
|
9 |
5 |
p. e300-e301
|
article
|
| 7 |
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
|
Madhi, Shabir A
|
|
|
9 |
5 |
p. e309-e322
|
article
|
| 8 |
Levelling up HIV testing for the endgame
|
The Lancet HIV,
|
|
|
9 |
5 |
p. e299
|
article
|
| 9 |
Moving forward with dolutegravir in children weighing less than 20 kg
|
Rabie, Helena
|
|
|
9 |
5 |
p. e301-e302
|
article
|
| 10 |
Pakistan continues to battle paediatric HIV outbreak
|
Burki, Talha
|
|
|
9 |
5 |
p. e307
|
article
|
| 11 |
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial
|
Ruel, Theodore D
|
|
|
9 |
5 |
p. e332-e340
|
article
|
| 12 |
Realising the potential of risk-informed PrEP
|
Schaefer, Robin
|
|
|
9 |
5 |
p. e302-e304
|
article
|
| 13 |
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
|
Netto, Lucas C
|
|
|
9 |
5 |
p. e323-e331
|
article
|
| 14 |
Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?
|
Schmidt, Heather-Marie A
|
|
|
9 |
5 |
p. e363-e366
|
article
|
Journal description